The company said, “Nano’s (NNDM) decision to nominate directors to the Stratasys (SSYS) Board was tied directly to its efforts to seek redemption of the poison pill to clear a path for Stratasys shareholders to realize significant value for their Stratasys shares through the $25 per share all cash special tender offer and ultimately combine the companies. Given the Stratasys Board continues to act out of self-preservation and refuses to remove or terminate the poison pill, thereby effectively preventing Nano’s special tender offer, Nano believes it is no longer practical to pursue the election of its nominees to the Stratasys Board and Nano is withdrawing its nominees.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NNDM:
- Nano Dimension Intends to Discontinue its Stratasys Special Tender Offer and Withdraw Director Nominees for Stratasys Board
- Stratasys says ISS, Glass Lewis recommend re-election of company nominees
- Nano Dimension Issues Presentation Highlighting the Need to Replace the Stratasys Board and Detailing Nano’s Value-Driven Path Forward for Stratasys
- Nano issues presentation highlighting ‘need’ to replace Stratasys board
- Nano Dimension to Release Q2/2023 Results on August 21st